Mammalian cell expression systems are the dominant tool today for producing complex biotherapeutic proteins. In this chapter, we discuss the basis for this dominance, and further explore why the Chinese hamster ovary (CHO) cell line has become the prevalent choice of hosts to produce most recombinant biologics. Furthermore, we explore some of the innovations that are currently in development to improve the CHO cell platform, from cell line specific technologies to overarching technologies that are designed to improve the overall workflow of bioprocess development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/10_2013_260 | DOI Listing |
Publication Analysis
Top Keywords
mammalian cell
8
cho cell
8
cell developments
4
developments speed
4
speed efficiency
4
efficiency mammalian
4
cell
4
cell expression
4
expression systems
4
systems dominant
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!